ArticleProstate cancer and prostatic diseases2026

Modern day cost analysis demonstrates medical therapy as a highly cost‑effective first‑line treatment for BPH/LUTS.

Alexis E Te et al.PubMed ↗Publisher ↗

No numbers read from the abstract.